Orange Book product · Generic (ANDA)
NYSTATIN AND TRIAMCINOLONE ACETONIDE
NYSTATIN; TRIAMCINOLONE ACETONIDE
At a glance
Aug 17, 2021
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 17, 2021
4 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
NYSTATIN; TRIAMCINOLONE ACETONIDE
Strength
100,000 UNITS/GM;0.1%
Dosage form
OINTMENT
Route
TOPICAL
TE code
AT
Application
ANDA 214751
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NYSTATIN; TRIAMCINOLONE ACETONIDE
- 2022NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 214181 · MACLEODS PHARMS LTD
- 2022NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 214186 · ALEMBIC
- 2021NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 214090 · ALEMBIC
- 2020NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 213142 · TORRENT
- 2019NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 207316 · CHARTWELL RX
- 2018NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 207764 · ZYDUS LIFESCIENCES
- 2018NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 208205 · LUPIN
- 2018NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 209990 · AMNEAL
- 2018NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 210077 · STRIDES PHARMA
- 2017NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 207730 · CROWN LABS INC
- 2017NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 207731 · CROWN LABS INC
- 2017NYSTATIN AND TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 208479 · PADAGIS ISRAEL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
